Alain Litwin
Addiction Medicine · Bronx, NYNPI 1366527368
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (50.7%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Gilead accounts for 89.6% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $66,291, 4.9 times the $13,600 reported in 2019. Among addiction medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 145 payments — averaging $853.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$111K
- Merck$13K
- Siemens Medical Solutions USA, Inc.$130
- AbbVie$58
- Alkermes, Inc.$26
Across 288 payments — averaging $5710.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Indivior Inc.$1M
- Gilead$628K
What the payments were for
- Consulting fees$45,01736%
- Speaking & faculty fees$62,67951%
- Travel & lodging$12,70010%
- Food & beverage$3,3053%
- Education$130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 138 | $110,849 |
| Merck | 2 | $12,650 |
| Siemens Medical Solutions USA, Inc. | 1 | $130 |
| AbbVie | 2 | $58 |
| Alkermes, Inc. | 2 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Epclusa$66,605
How this compares
$123,714 in reported general payments places this provider in the 95th percentile of 125 addiction medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 32 | $2,725 |
Paid to pharmacies, not to this prescriber.
Other addiction medicine in Bronx
- Edmond HakimiCalverton$125K
- John MarianiNew York$38K
- Stefan KantrowitzNew York$33K
- Alejo ParelladaBrooklyn$22K
- Sean ChappinAlbany$20K
- Mohammad KabirTroy$15K
- Sonia LopezJamaica$14K
- Thomas KuettelWorcester$14K
- Ramon RaveloNew York$13K
- Stuart GitlowNew York$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.